ANNALISA JENKINS

ex Global Head of R&D at Merck Serono and
ex Global Medical SVPat Bristol Myers Squibb

All rights reserved ©2024 Turbine Ltd.  |   Privacy Policy  |   Created by Art&Board Studio
Head of Lab Csilla Laczka, PhD, DSc and Co-Founder, Translational Scientist Iván Fekete M.D. will present our poster about a novel drug target and its mechanism of action at European Association for Cancer Research (EACR) Congress in Rotterdam, from June 10.
Read our poster for EACR 2024! - The Simulated Cell™ identifies LIG4 as a novel target in PARPi resistance via the modulation of NHEJ deficiency